Research links COVID-19 to rise in childhood type 1 diabetes
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
INST-Mohali develops oral nano-medicines for Kala-Azar and other neglected diseases
According to the INST team, till-date there is no study reported where a combination of two anti-leishmanial drugs has been…
Researchers develop technology to see inside cells
The new technology may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more
Pakistan to conduct phase-III clinical trial of COVID-19 vaccine from CanSinoBio
The NIH said this would be the first-ever phase-III clinical trial for any vaccine in Pakistan
CARE consortium launched to fast-track discovery and development of medicines to treat COVID-19
The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies
Scientists ascertain 73 novel variants of COVID-19 strain in Odisha
The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112…
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent
Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis
The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later…
Virus uses ‘decoy’ strategy to evade immune system: Otago researchers
The research demonstrates another manner in which viruses are capable of hijacking infected cells and alerts scientists to the…
Scientists leverage AI to find COVID-19 drug candidates
They identified the best-in-class hits for the 65 human proteins that interact with SARS-CoV-2 proteins
India-Sweden Healthcare Innovation Centre launches ‘Innovation Challenge’
It is an opportunity for start-ups to collaborate with partners on the Innovation Centre platform to help solve some of the…
Stanford study reveals immune-system deviations in severe COVID-19 cases
The study revealed, paradoxically, that the worse the case of COVID-19, the less effective certain cells of the innate immune…
American Gene Technologies gets US FDA nod for Phase 1 clinical trial of potential HIV cure
AGT’s Phase 1 trial will investigate the safety of AGT103-T, a single-dose, lentiviral vector-based gene therapy, and measure key…
IIT Mandi team compares disordered proteins in COVID-19 virus through computational studies
Understanding the structure and functions of intrinsically disordered proteins (IDPs), and intrinsically disordered protein…
Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19
Its study analyses lipid mediators, known as leukotrienes, as the cause for hyperinflammatory response manifested in severe…
Hilleman Labs is developing a liquid form of meningococcal vaccine in a single container closure
Hilleman Labs (HL) has been working on the development of vaccine technologies against some of the key causes of bacterial…
UK-India experts’ drive to stop antibiotic waste creating more ‘superbugs’
The project is part of £8 million package of UK-India government-backed research which also comprises programmes to tackle AMR…
Pankajakasthuri declares final clinical trials of ZingiVir-H as adjunct therapy for COVID-19…
Patients reported negative RT PCR recovery in an average of five days, all results submitted to AYUSH for necessary approval
Centre to come up with R&D policy for pharma sector: DoP Secretary
He informed that the government is planning to set up three national CoEs for drugs, medical devices in the country and NIPER…
Zydus Cadila completes dosing in Phase I clinical trial of ZyCoV-D
Phase II trial to commence on August 6, 2020